Prasugrel

CHEMBL1201772 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
373.4 g/mol
LogP
3.6
Phase
4

A blood-thinning medication used to prevent heart attacks and strokes in people who have had a heart attack or severe chest pain and were treated with a procedure to open blocked coronary arteries. It works by preventing blood platelets from clumping together to form dangerous clots.

Moleküler Ağırlık

373,4000 g/mol

LogP

3,60

TPSA

74,90 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2

InChI

InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3

Molecular Formula

C20H20FNO3S

HBD / HBA

- / 6

Döndürülebilir Bağlar

6

Ağır Atomlar

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A blood-thinning medication used to prevent heart attacks and strokes in people who have had a heart attack or severe chest pain and were treated with a procedure to open blocked coronary arteries. It works by preventing blood platelets from clumping together to form dangerous clots.

Yes, Prasugrel is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201772. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6918456. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.